Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Progress in adjuvant chemotherapy for breast cancer: an overview
2015
New adjuvant strategies for breast cancer: Meeting the challenge of integrating chemotherapy and trastuzumab (Herceptin)
2001
Cardiotoxic effects of anthracycline–taxane combinations
2003
Breast cancer
2016 Standout
Chemistry and biology of monoterpene indole alkaloid biosynthesis
2006 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment
2017 StandoutNobel
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
The Pictet–Spengler Reaction in Nature and in Organic Chemistry
2011 Standout
Doxorubicin‐paclitaxel
2002
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Noncoding RNA activated by DNA damage (NORAD): Biologic function and mechanisms in human cancers
2018
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor
2000
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Assessment of the therapeutic activity of a combination of almitrine and raubasine on functional rehabilitation following ischaemic stroke
2004
Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer
2000
Tumor delivery of macromolecular drugs based on the EPR effect
2010 Standout
Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer
2001
Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I–II study
2000
Phase I Study of Paclitaxel (Taxol) and Pegylated Liposomal Doxorubicin (Caelyx) Administered Every 2 Weeks in Patients with Advanced Solid Tumors
2002
The Value of Adjuvant Treatment in Young Women with Breast Cancer
2002
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
Phase I Trial of Pegylated Liposomal Doxorubicin and Docetaxel in Advanced Breast Cancer
2001
Fault diagnosis based on dependent feature vector and probability neural network for rolling element bearings
2014
Multicenter Randomized Trial Comparing Sequential With Concomitant Administration of Doxorubicin and Docetaxel As First-Line Treatment of Metastatic Breast Cancer: A Spanish Breast Cancer Research Group (GEICAM-9903) Phase III Study
2004
Acoustic Emission Characteristics of Graded Loading Intact and Holey Rock Samples during the Damage and Failure Process
2019
Pharmacokinetic profiles of doxorubicin in combination with taxanes
2001
Guidelines for the Primary Prevention of Stroke
2014 Standout
Injection-Induced Earthquakes
2013 StandoutScience
Mechanisms of Cancer Drug Resistance
2002 Standout
Blinded, Randomized, Multicenter Study to Evaluate Single Administration Pegfilgrastim Once per Cycle Versus Daily Filgrastim as an Adjunct to Chemotherapy in Patients With High-Risk Stage II or Stage III/IV Breast Cancer
2002
Phase III Study of Doxorubicin/Cyclophosphamide With Concomitant Versus Sequential Docetaxel As Adjuvant Treatment in Patients With Human Epidermal Growth Factor Receptor 2–Normal, Node-Positive Breast Cancer: BCIRG-005 Trial
2011
HU-211, a Novel Noncompetitive N -Methyl- d- Aspartate Antagonist, Improves Neurological Deficit and Reduces Infarct Volume After Reversible Focal Cerebral Ischemia in the Rat
1995
Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial
2001
Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial
2003
A review of recent studies of triggered earthquakes by artificial water reservoirs with special emphasis on earthquakes in Koyna, India
2002
Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial
2006
A review on signal processing techniques utilized in the fault diagnosis of rolling element bearings
2016 Standout
Characteristics and trends of coal mine safety development
2020 Standout
Works of Ping Hu being referenced
Neurologic and histologic evaluation of almitrine + raubasine (Duxil®) in middle cerebral artery occlusion in cats
1993
Phase II Trial of Doxorubicin and Paclitaxel Plus Granulocyte Colony-Stimulating Factor in Metastatic Breast Cancer: An Eastern Cooperative Oncology Group Study
1999
DESIGN OF AUTO-BODY PANEL ADDENDUM BASED ON SWEEP SURFACE
2006
Brittle Failure Mechanism of Multiple Locked Patches in a Seismogenic Fault and Exploration of a New Approach to Earthquake Prediction
2010
Induced seismicity at wujiangdu reservoir, China: a case induced in the karst area
1996
lncRNA NORAD Contributes to Colorectal Cancer Progression by Inhibition of miR-202-5p
2018